Devi GR - Search Results

1

c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.

Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR. Sekhon HS, et al. Among authors: devi gr. Lung Cancer. 2008 Jun;60(3):347-54. doi: 10.1016/j.lungcan.2007.10.028. Epub 2007 Dec 21. Lung Cancer. 2008. PMID: 18096271

2

Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.

Devi GR, Oldenkamp JR, London CA, Iversen PL. Devi GR, et al. Prostate. 2002 Nov 1;53(3):200-10. doi: 10.1002/pros.10151. Prostate. 2002. PMID: 12386920

3

Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.

Knapp DC, Mata JE, Reddy MT, Devi GR, Iversen PL. Knapp DC, et al. Among authors: devi gr. Anticancer Drugs. 2003 Jan;14(1):39-47. doi: 10.1097/00001813-200301000-00006. Anticancer Drugs. 2003. PMID: 12544257

4

Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR. Iversen PL, et al. Among authors: devi gr. Clin Cancer Res. 2003 Jul;9(7):2510-9. Clin Cancer Res. 2003. PMID: 12855625 Clinical Trial.

5

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR. London CA, et al. Among authors: devi gr. Cancer Gene Ther. 2003 Nov;10(11):823-32. doi: 10.1038/sj.cgt.7700642. Cancer Gene Ther. 2003. PMID: 14605668

6

X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.

Amantana A, London CA, Iversen PL, Devi GR. Amantana A, et al. Among authors: devi gr. Mol Cancer Ther. 2004 Jun;3(6):699-707. Mol Cancer Ther. 2004. PMID: 15210856

7

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. Ko YJ, et al. Among authors: devi gr. J Urol. 2004 Sep;172(3):1140-4. doi: 10.1097/01.ju.0000134698.87862.e6. J Urol. 2004. PMID: 15311058

8

Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.

Arora V, Devi GR, Iversen PL. Arora V, et al. Among authors: devi gr. Curr Pharm Biotechnol. 2004 Oct;5(5):431-9. doi: 10.2174/1389201043376706. Curr Pharm Biotechnol. 2004. PMID: 15544491

9

In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.

Devi GR, Beer TM, Corless CL, Arora V, Weller DL, Iversen PL. Devi GR, et al. Clin Cancer Res. 2005 May 15;11(10):3930-8. doi: 10.1158/1078-0432.CCR-04-2091. Clin Cancer Res. 2005. PMID: 15897595 Clinical Trial.

10

Cellular uptake of neutral phosphorodiamidate morpholino oligomers.

Iversen PL, Aird KM, Wu R, Morse MM, Devi GR. Iversen PL, et al. Among authors: devi gr. Curr Pharm Biotechnol. 2009 Sep;10(6):579-88. doi: 10.2174/138920109789069279. Epub 2009 Sep 1. Curr Pharm Biotechnol. 2009. PMID: 19619124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters